Patient Capital Management highlights Q2 winners like QXO and Nvidia, while exiting NFE over default risks. See what’s ...

Amid a cautious outlook, Biogen has presented new data at the Alzheimer’s Association International Conference (AAIC) 2025, demonstrating that investigational Leqembi 360 mg subcutaneous maintenance ...

Biogen Inc. (NASDAQ:BIIB) is one of the top 10 medical AI companies to buy according to analysts. On July 14, UBS reiterated ...

Pharma stock under pressure as Trump plans to hike pharmaceutical tariffs up to 250%, aiming to boost U.S. production. Read more here.